Community Health Systems, Inc. (CYH) Earnings
Community Health Systems, Inc. is expected to report next earnings on July 22, 2026 (in NaN days), with a consensus EPS estimate of $-0.10. CYH has beaten EPS estimates in 3 of its last 12 reported quarters (average surprise -17.7% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 22, 2026 | $-0.11 | $-0.48 | -323.1% | $3.0B | +0.5% |
| Feb 18, 2026 | $-0.20 | $-0.42 | -105.2% | $3.1B | -1.0% |
| Oct 23, 2025 | $-0.28 | $1.27 | +557.4% | $3.1B | +3.2% |
| Jul 23, 2025 | $0.05 | $-0.05 | -200.0% | $3.1B | +4.3% |
| Apr 23, 2025 | $-0.10 | $-0.03 | +70.0% | $3.2B | +3.5% |
| Feb 18, 2025 | $0.09 | $-0.42 | -566.7% | $3.3B | +4.1% |
| Oct 23, 2024 | $-0.16 | $-0.30 | -87.5% | $3.1B | -1.5% |
| Jul 24, 2024 | $-0.11 | $-0.17 | -54.5% | $3.1B | +2.4% |
| Feb 20, 2024 | $-0.04 | $-0.41 | -819.3% | $3.2B | +0.8% |
| Oct 25, 2023 | $-0.16 | $-0.33 | -106.3% | $3.1B | +0.8% |
| Aug 2, 2023 | $-0.29 | $-0.22 | +24.1% | $3.1B | +1.7% |
| May 1, 2023 | $-0.22 | $-0.43 | -95.5% | $3.1B | +0.6% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · April 22, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Kevin Hammons acknowledged employees, physicians, and teammates. Earlier this week, announced significant investments in ambulatory surgery centers including pending acquisition of Surgical Institute of Alabama. Top priorities include enhancing quality, patient experience, physician experience, and employee satisfaction. Realizing operational improvements at accelerating pace. Expect 80% of CHS's hospitals to receive leapfrog A or B grade next month, up from 48% a year ago. 56% of hospitals to receive CMS rating of three or more stars, up from 45% in 2025. Deploying ambient listening technology in clinics and hospitals to reduce administrative burdens. Jason Johnson reviewed financial results, noted adjusted EBITDA was low end of expectations, divestitures had negative impact, same-store net revenue increased, labor cost managed, supplies expense controlled, cash flows from operations were use of $297 million. Completed divestitures, redeemed notes, announced divestiture of Arkansas hospitals, made ASC investments
Guidance
Financial guidance for 2026 remains unchanged. Initial range for adjusted EBITDA $1.34 to $1.49 billion. New developments like Georgia's State Director Payment Program, Arkansas divestiture, and ASC investments captured within range. Multiple items on horizon could affect guidance, like potential new state drug repayment programs and Rural Health Transformation Program
Segment performance
Adjusted EBITDA for the first quarter was 309 million with margin of 10.4%. Recently divested hospitals produced approximately $25 million of negative adjusted EBITDA in the first quarter. Same-store net revenue increased 3.1% year-over-year, driven by 3.7% growth in net revenue per adjusted admission, partly offset by a 0.5% decline in same-store adjusted admissions. Labor cost was well managed overall with approximately 2% year-over-year growth in average hourly rate and same-store contract labor spend down 11%. Supplies expense remained well controlled, declining 60 basis points year over year to 14.9% net revenue. Medical specialist fees were up approximately 11% year over year
Risks & headwinds
Forward-looking statements subject to known and unknown risks described in risk factors in annual report on Form 10-K and other SEC filings. Volume and impairments below expectations, softness in procedures like hips and knees, negative contribution from divested operations, macroeconomic disruptions, consumer fears related to geopolitical instability and increased cost of living, aggressive practices by managed care companies delaying payments